Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03801993 · ClinicalTrials.gov registry record
Multicenter Study of Patient-reported Gastrointestinal Symptoms in People With Cystic Fibrosis
A clinical trial, sponsored by Chris Goss.
- Completed
- Registry status
- 402
- Enrollment target
NCT03801993: Completed study, sponsored by Chris Goss.
NCT03801993 is a clinical trial that has completed, run by Chris Goss. The registered enrollment target is 402 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03801993 has completed, sponsored by Chris Goss.
- COMPLETED
- Registry status
- 402 participants
- Enrollment target
Study Summary
This is a prospective, multicenter, observational study designed to collect gastrointestinal related data in patients with Cystic Fibrosis (CF).
Primary Outcome
Number participants with scheduled outside-the-clinic assessments who fully completed at least one of the four PROs. A "fully complete" questionnaire is defined as having responded to all questions with no missing responses.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 402 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2019-09-17 |
What the finished NCT03801993 record still lists
NCT03801993 is an observational study that tracks outcomes without assigning an intervention. The registered 402 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03801993 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03801993 about?
NCT03801993 is a clinical study titled "Multicenter Study of Patient-reported Gastrointestinal Symptoms in People With Cystic Fibrosis". This is a prospective, multicenter, observational study designed to collect gastrointestinal related data in patients with Cystic Fibrosis (CF).
What is the current status of trial NCT03801993?
This trial is currently completed. The enrollment target is 402 participants. The study started on 2019-05-01. Estimated completion is 2019-09-17.
Who is sponsoring clinical trial NCT03801993?
This trial is sponsored by Chris Goss, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04464226 · 402 participants · Phase 3
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
- NCT05183763 · 402 participants · NA
Medication Adherence Program
- NCT06748222 · 402 participants · Phase 3
E-Mindfulness Approaches for Living After Breast Cancer
- NCT06896474 · 402 participants · NA
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI